B of A Securities Downgrades PTC Therapeutics to Underperform, Announces $38 Price Target
B of A Securities analyst Tazeen Ahmad downgrades PTC Therapeutics (NASDAQ:PTCT) from Neutral to Underperform and announces $38 price target.
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 6)
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 5)
PTC Therapeutics’ Rare Genetic Disease Gene Therapy Shows Durable Improvement Even At 5 Years
PTC Therapeutics Inc (NASDAQ:PTCT) presented a new analysis of five-year results of gene therapy, PTC-AADC. The data exhibited improvements in children…
PTC Therapeutics Announces Results Show Long-Lasting And Holistic Improvements In Children With AADC Deficiency Treated With PTC-AADC Gene Therapy
PTC Therapeutics, Inc. (NASDAQ:PTCT) today presented a new analysis of five-year results that shows its novel gene therapy, PTC-AADC, leads to profound improvements in children with aromatic L-Amino acid decarboxylase
58 Biggest Movers From Yesterday
Gainers
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares surged 73.4% to close at $12.80 on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares jumped 101% to $14.87 following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
The Daily Biotech Pulse: Restricted Authorization For Pfizer’s COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 22)
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 20)